Updated:
NMT Capital
NMT Capital is a private equity firm investing across stages in medical technology, life sciences, and enterprise software, with funds in the US and Europe.
NMT Capital
NMT Capital is a private equity firm based in Norwell, US. It focuses on a Venture Capital investment approach.
General information
Firm type
Private Equity
Year founded
2004
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Norwell
Corporate office
Norwell, MA, United States
Additional offices
Quincy, MA · San Francisco, CA · London, UK · Munich, Germany · Geneva, Switzerland · Tokyo, Japan
Sector focus
Frequently asked questions
How does NMT Capital source its investment opportunities?
NMT Capital operates a dual sourcing engine. As a principal investor it evaluates deals for its own funds; simultaneously it acts as a paid consultant to global investment banks seeking to source and evaluate private medical companies. This advisory work gives NMT early visibility into companies considering a sale or capital raise, creating a proprietary pipeline not available to firms relying solely on standard GP networks.
Does NMT Capital invest directly, or only through funds?
NMT primarily invests through managed pooled funds based in the US and Europe. It does not market itself as a direct-deal platform for external LPs and does not invite co-investment from outside the vehicle structure. Given its advisory work for investment banks, the firm likely structures investments to avoid conflicts between its principal investments and the mandates it executes for bank clients.
What stages does NMT Capital target?
NMT Capital invests across the full spectrum, from seed and early-stage venture capital through growth and late-stage expansion to buyouts. This multi-stage approach allows the firm to back companies at inception via its venture allocation and supply follow-on capital via its growth and buyout vehicles as those companies mature.
Which sectors fall outside NMT Capital's investment mandate?
NMT's disclosed focus is limited to medical technology, life sciences, advanced materials, software, communications, and information technology. The firm does not list consumer, fintech, energy, real estate, or infrastructure as target sectors, indicating a concentrated technical and healthcare-driven mandate.
How are NMT Capital's advisory and investment activities separated?
The firm describes its advisory services as a distinct consulting line assisting investment banks in sourcing and evaluating private medical companies, but it does not publicly detail how it prevents information asymmetry between its advisory clients and its own fund portfolios. The same principals averaging more than 20 years of experience oversee both activities.
Does NMT Capital have any disclosed fund sizes or AUM?
NMT Capital does not publicly disclose assets under management, cumulative deployment, or fund sizes. Its web presence is limited to a single-page description of strategy and geography, and no public SEC filing or press release has been identified that reports a fund size or AUM figure.
Is NMT Capital a single-family office or a traditional private equity firm?
NMT Capital is structured as a private equity firm managing pooled funds, not a single-family office. The firm invests institutional and external capital through US and European fund vehicles, with no indication of a single-family wealth origin.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: